It should only be considered an indication and not a recommendation. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through … AstraZeneca is borrowing $17.5 billion to fund the acquisition. View the current price trend and analyse the historical price charts. ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website. There are no documents available for this stock. The acquisition is expected to close in the third quarter of 2021. (ix) The volume weighted average price of an Alexion Share is derived from Bloomberg by reference to the volume weighted average price over the last 30 Alexion trading days up to 11 December 2020 (being the last Business Day prior to announcement of an offer for Alexion). Dividend information for this stock is not available. Discover historical prices for ALXN stock on Yahoo Finance. Though Alexion's share price rose around 10% this year, it remains well below the $200-per-share crest hit in mid-2015. article's content and its accuracy. The selling price currently displayed is higher than the buying price. The demand for shares of the company looks higher than the supply. Try our handy filter to explore the different options. Share Price & News. Comparatively, Alexion Pharmaceuticals has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Alexion shares closed at around $121 apiece on Friday. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion … Companies with negative earnings receive an "NE." There are no documents available for this stock. Company Secretary . View recent trades and share price information for Alexion Pharmaceuticals Inc USD0.0001 The offer values Alexion at $175 a share, a 45% premium to the closing price on Friday. As of 2017 Alexion Pharmaceuticals shares are mainly held by 735 institutional investors (Fidelity Investments, T. Rowe Price, BlackRock and others) Products Specialty drugs Alexion has employed a strategy of developing drugs to combat rare diseases. To buy shares in , you'll need to have an account. Alexion Pharmaceuticals share price volatility. It gives AstraZeneca a foothold in the rare disease market, and a new Boston-based business unit will be set up, led by Alexion management. Based on a reference average ADR price of $54.14, that implies a total price of $175 per share. Alexion Pharmaceuticals Stock Forecast, ALXN stock price prediction. AstraZeneca’s offer for Alexion values the smaller company at $39bn. access. Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Alexion Pharmaceuticals share price volatility. Alexion’s fourth-quarter adjusted earnings of $2.96 per share comfortably beat the Zacks Consensus Estimate of $2.50 and grew from $2.71 in the year-ago period. This and other conditions can cause a rise in the share price in the next days. Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. For Alexion, a sale brings an end to a frustrating saga. We may not share With a price-to-earnings (or "P/E") ratio of 27x Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 19x and even P/E's lower than 10x are not unusual.However, the P/E might be high for a reason and it requires further investigation to determine if it's justified. Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. Company news for this stock is not available. AstraZeneca’s surprise $39billion takeover bid for US biotech firm Alexion wiped 9.2% from its share price early today as investors struggled to identify benefits from the mammoth deal. Coronavirus - we're here to help Over the last year, Alexion Pharmac share price has been traded in a range of 81.53464, hitting a high of 161.65318, and a low of 80.11854. (ix) The volume weighted average price of an Alexion Share is derived from Bloomberg by reference to the volume weighted average price over the last 30 Alexion trading days up to 11 December 2020 (being the last Business Day prior to announcement of an offer for Alexion). Alexion Pharmaceuticals stock was originally listed at a price of $3.13 in Dec 31, 1997 . access. If you're not sure which ALXN | Complete Alexion Pharmaceuticals Inc. stock news by MarketWatch. The high price target for ALXN is $196.00 and the low price target for ALXN is $73.00. With Alexion Pharmaceuticals stock trading at $152.75 per share, the total value of Alexion Pharmaceuticals stock (market capitalization) is $33.43B. Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'. wellbeing and our community we're The selling price currently displayed is higher than the buying price. Even after Ultomiris’ launch in late 2018, the company’s stock price has stayed pretty much flat. At the current price of $153.53, shares in Alexion … But if … ALXN.US volatility (beta: 1.34) Avg. Volatility Over Time: ALXN's weekly volatility (9%) has been stable over the past year. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion share. agencies. Other top laggards in the FTSE are Fresnillo, PolyMetal, and BHP. Though Alexion's share price rose around 10% this year, it remains well below the $200-per-share crest hit in mid-2015. Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. Buy. Stable Share Price: ALXN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week. investments are right for you, please request advice, for example from our, Register for online Alexion Pharmaceuticals Share Price (ALXN) Follow ALXN. Latest Share Price and Events. Alexion closed at $120.97 Wednesday, a 3.4% decrease from the same date three years ago. View recent trades and share price information for Alexion Pharmaceuticals Inc and other shares. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or … Share Name Share Symbol Market Type; Alexion Pharmaceuticals Inc: NASDAQ:ALXN: NASDAQ: Common Stock Price Change % Change Share Price Shares Traded Last Trade : 0.00: 0.0%: 152.61: 0: 00:00:00: Bid Price Offer Price High Price Low Price Open Price; 152.61: 153.77: Industry Sector Turnover (m) Profit (m) EPS - … Latest Share Price and Events. To buy shares in , you'll need to have an account. It should only be considered an indication and not a recommendation. Our analysts have selected this fund for the Wealth Shortlist. here to help. Alexion Pharmac Share Chat. Free copies of these documents may be obtained as described in the paragraphs above. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shareholders should be happy to see the share price up 12% in the last quarter.But that doesn't change the fact that the returns over the last five years have been less than pleasing. The price represented more than a 135% premium over ... Alexion announced an agreement to acquire Portola Pharmaceuticals for $18 per share using cash. Ahead of Saturday's announcement, shares were sitting at $120 apiece. Beta is a measure of a share's volatility in relation to the market. Coronavirus - we're here to help * To buy US shares you must first complete and return a US government, Our website offers information about investing and saving, but not personal advice. Newsroom articles are published by leading news The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal. Company announcements for this stock is not available. Alexion Pharmaceuticals (NASDAQ:ALXN) Share Price and News. Often, the quality of the stock makes all the difference. Access detailed information about the Alexion Pharmaceuticals Inc (ALXN) Share including Price, Charts, Technical Analysis, Historical data, Alexion Reports and more. Other top laggards in the FTSE are Fresnillo, PolyMetal, and BHP. We may not share Price trends tend to persist, so it's worth looking at them when it comes to a share like Alexion Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 25.86%. Hargreaves Lansdown is not responsible for an Adrian Kemp Company Secretary AstraZeneca PLC _____ 1 A rare disease is a disease impacting less than 200,000 patients … AstraZeneca’s takeover is a bet on rare diseases and immunology in … This move was aimed to diversify Alexion's hematology, neurology, and critical care commercial portfolio with Portola's Factor Xa inhibitor reversal agent. With Alexion Pharmaceuticals stock trading at $152.75 per share, the total value of Alexion Pharmaceuticals stock (market capitalization) is $33.43B. From how to access your account online, scam awareness, your Alexion Pharmaceuticals Inc (ALXN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Alexion Pharmaceuticals Inc,ALXN,ISIN: US0153511094 - view the latest price,charts and performance information at AJ Bell Youinvest Skip to main content Alexion Pharmaceuticals Inc (NASDAQ:ALXN) - Share price At $175 a share, this represents a 45% premium on Alexion’s share price. How has Alexion Pharmaceuticals's share price performed over time and what events caused price changes? Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. The Alexion Pharmaceuticals Inc share price has moved by 51.6% over the past three months. investments are right for you, please request advice, for example from our, Register for online The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. What appears to be exercising some who follow AstraZeneca is the price it is paying. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. Information about the directors and executive officers of Alexion and their ownership of Alexion shares is set forth in is set forth in Alexion’s Annual Report on Form 10-K/A, as previously filed with the SEC on February 16, 2021. The acquisition is expected to close in the third quarter of 2021. Sell. We don’t know yet if this offer will be accepted by Alexion shareholders. Earnings and Valuation This table compares Vertex Pharmaceuticals and Alexion Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation. Earnings Per Share: The trailing 12 months EPS from total operations is the bottom line income after all expenses, divided by the weighted average number of common shares outstanding. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. Moreover, revenues rose 15% year over year to $1.59 billion for the reported quarter and … Based on a reference average ADR price of $54.14, that implies a total price of $175 per share. Newsroom articles are published by leading news Stable Share Price: ALXN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week. If you're not sure which The latest Alexion Pharmaceuticals Inc share price. the views of the author. We're sorry for any inconvenience this may cause. After all, the share price is down 27% in that time, significantly under-performing the market. A popular way to gauge a stock's volatility is its "beta". wellbeing and our community we're ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes various therapeutic products. Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'. The latest Alexion Pharmaceuticals Inc share price. Over the last 12 months, Alexion Pharmaceuticals's shares have ranged in value from as little as $72.67 up to $162.6. Alexion Pharmaceuticals stock was originally listed at a price of $3.13 in Dec 31, 1997 . To invest in , you'll need to open an account.Try our handy filter to find which one suits you best. the views of the author. Contextual immersion trading strategy idea. article's content and its accuracy. See the latest Alexion Pharma share price and client sentiment. agencies. $39bn cash/share deal looks manageable. Interactive Chart for Alexion Pharmaceuticals, Inc. (ALXN), analyze all the data with a huge range of indicators. Analysts viewed Alexion’s purchase price as a heavy premium to its $121 per share closing price on Friday. Chat About 0QZM Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary. Share Price & News. Over the last 12 months, Alexion Pharmaceuticals's shares have ranged in value from as little as $72.67 up to $162.6. The offer represents a 45% premium to Alexion's share price prior to the announcement of the deal. Alexion (ALXN) is set to be acquired by AstraZeneca for $39 billion or $175 per share. Alexion's investors will receive £45 cash and 2.1 Astra shares for each Alexion share – or £132 per share, a 45 per cent premium – handing them 15 per cent of the combined company. Adrian Kemp . Forward-looking Information Alexion Pharmaceuticals, Inc. Common Stock (ALXN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Try our handy filter to explore the different options. Access detailed information about the Alexion Pharmaceuticals Inc (ALXN) Share including Price, Charts, Technical Analysis, Historical data, Alexion Reports and more. 24 Wall Street analysts have issued ratings and price targets for Alexion Pharmaceuticals in the last 12 months. A popular way to gauge a stock's volatility is its "beta". From how to access your account online, scam awareness, your Dividend information for this stock is not available. The deal, the largest in AstraZeneca’s history, is expected to close in the third quarter of 2021. Price/Earnings: Latest closing price divided by the earnings-per-share based on the trailing 12 months. The latest Alexion Pharmaceuticals Inc USD0.0001 share price. Appeasing Alexion investors. Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Their average twelve-month price target is $155.00, predicting that the stock has a possible upside of 1.97%. volatility (beta: 1.00) Low High. In volatile markets, many investors are keen to buy what they think are cheap stocks - but it's essential to recognise the difference between a genuine bargain and a value trap. The offer values Alexion at $175 a share, a 45% premium to the closing price on Friday. volatility (beta: 1.00) Low High. * To buy US shares you must first complete and return a US government, Our website offers information about investing and saving, but not personal advice. here to help. AstraZeneca has agreed to buy Alexion Pharmaceuticals in a mixed cash and shares deal worth $39bn. Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Alexion shares closed at around $121 apiece on Friday. Due to changes in how we source investment data, Broker Forecasts are not available. AstraZeneca’s share price has now fallen by more than 20% from the 52-week high of 10,120p seen earlier this year. Beta is a measure of a share's volatility in relation to the market. AstraZeneca share price is the worst-performer in the FTSE 100 today. Alexion's investors will receive £45 cash and 2.1 Astra shares for each Alexion share – or £132 per share, a 45 per cent premium – handing them 15 per cent of the combined company. How has Alexion Pharmaceuticals's share price performed over time and what events caused price changes? View recent trades and share price information for Alexion Pharmaceuticals Inc and other shares. Our analysts have selected this fund for the Wealth Shortlist. Volatility Over Time: ALXN's weekly volatility (9%) has been stable over the past year. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion share. To invest in , you'll need to open an account.Try our handy filter to find which one suits you best. Annual & interim reports are not available for this stock. This represents a … View daily, weekly or monthly … This represents a 45% premium to Alexion's closing share price on … Latest Alexion Pharmaceuticals Inc (ALXN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. ALXN.US volatility (beta: 1.34) Avg. Hargreaves Lansdown is not responsible for an Based on AstraZeneca's reference average ADR price of $54.14, this implies a total consideration of $39 billion or $175 per share to Alexion’s shareholders. AstraZeneca share price is the worst-performer in the FTSE 100 today. Recent trade data is unavailable. It’s the largest deal for AstraZeneca since it was founded in a 1999 combination of British and Swedish companies, and would entrench its position among the world’s 10 biggest drugmakers. View real-time stock prices and stock quotes for a full financial overview. Though the biotech has consistently achieved revenue growth in the double digits, its stock price has gone in the opposite direction since peaking at nearly $210 in mid-2015. The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal.